TRHC News and Press, Tabula Rasa HealthCare Inc. From 03/30/22

Tabula Rasa HealthCare (NASDAQ:TRHC) rose 1.5% after a report that the company is said be exploring options for some of its businesses. TRHC is exploring options for its PrescribeWellness and medication therapy management units, according to an Axios Pro report. Talks are taking place wi...

Tabula Rasa HealthCare (TRHC +6.3%) announced a 5-year renewal with Gary and Mary West PACE for its CareKinesis PACE Pharmacy and Pharmastar services. Gary and Mary West PACE is a Program of All-inclusive Care for the Elderly in San Marcos, CA. CareKinesis is a leadin...

Tabula Rasa HealthCare Announces Partnership Extension with Gary and Mary West PACE PR Newswire TRHC will continue to provide the North County San Diego PACE program with medication safety, pharmacy, and pharmacy benefit solutions MOORESTOWN, N.J. , March...

New Study Further Validates Cost Savings from Unique Medication Risk Mitigation Technology PR Newswire PACE participants who received their medication through CareKinesis® had significantly reduced annual medical expenses related to unintended multi-drug interaction...

Tabula Rasa HealthCare, Inc. (TRHC) Q4 2021 Earnings Conference Call February 25, 2022, 08:30 AM ET Company Participants Kevin Dill - Corporate Counsel Calvin Knowlton - Founder, Chairman and CEO Orsula Knowlton - Co-Founder, President and Chief Marketing/New Business Development Officer Bria...

Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...

The following slide deck was published by Tabula Rasa HealthCare, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Tabula Rasa HealthCare, Inc. 2022 Q4 - Results - Earnings Call Presentation

Tabula Rasa HealthCare press release (NASDAQ:TRHC): Q4 GAAP EPS of -$0.91 misses by $0.10. Revenue of $85.7M (+11.2% Y/Y) beats by $0.47M. For further details see: Tabula Rasa HealthCare GAAP EPS of -$0.91 misses by $0.10, revenue of $85.7M beats by $0.47M

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results - Fourth quarter and full year 2021 revenue grew 11% and 11% (7% on an organic basis), respectively, year-over-year. - Fourth quarter and full year 2021 CareVention HealthCare revenue grew 16% and 20% (...

Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...